These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30459769)

  • 1. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against
    Bottero D; Zurita ME; Gaillard ME; Carriquiriborde F; Martin Aispuro P; Elizagaray M; Bartel E; Castuma C; Hozbor D
    Front Immunol; 2018; 9():2501. PubMed ID: 30459769
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 3. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.
    Zhang X; Goebel EM; Rodríguez ME; Preston A; Harvill ET
    Infect Immun; 2009 Nov; 77(11):5050-8. PubMed ID: 19737902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
    Zhang X; Rodríguez ME; Harvill ET
    PLoS One; 2009 Sep; 4(9):e6989. PubMed ID: 19750010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2003 Feb; 71(2):733-8. PubMed ID: 12540552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.
    Gorgojo J; Lamberti Y; Valdez H; Harvill ET; Rodríguez ME
    Infect Immun; 2012 Dec; 80(12):4309-16. PubMed ID: 23027528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
    Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
    Khelef N; Danve B; Quentin-Millet MJ; Guiso N
    Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O antigen protects Bordetella parapertussis from complement.
    Goebel EM; Wolfe DN; Elder K; Stibitz S; Harvill ET
    Infect Immun; 2008 Apr; 76(4):1774-80. PubMed ID: 18285500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
    Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
    Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
    Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
    Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Bordetella O antigen in respiratory tract infection.
    Burns VC; Pishko EJ; Preston A; Maskell DJ; Harvill ET
    Infect Immun; 2003 Jan; 71(1):86-94. PubMed ID: 12496152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative role of immunoglobulin A in protective immunity against the Bordetellae.
    Wolfe DN; Kirimanjeswara GS; Goebel EM; Harvill ET
    Infect Immun; 2007 Sep; 75(9):4416-22. PubMed ID: 17591791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.
    van den Berg BM; Beekhuizen H; Mooi FR; van Furth R
    Infect Immun; 1999 Mar; 67(3):1050-5. PubMed ID: 10024542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.
    Wolfe DN; Kirimanjeswara GS; Harvill ET
    Infect Immun; 2005 Oct; 73(10):6508-13. PubMed ID: 16177324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.